Tech & Wearableswell supported · human data

Fitness trackers nudged real weight loss but left blood pressure untouched

Across 26 randomised trials in 2373 overweight or obese adults, wearable and smartphone-based interventions increased daily steps, moderate-to-vigorous activity and quality of life, and reduced body weight by 1.61 kg on average, but blood pressure and resting heart rate did not change.

Compiled by FitTools from the study cited below

The citation, figures and study details on this page are taken mechanically from the source record. No human editor has reviewed it.

Added to Pulse 11 October 2026

Study design
Meta-analysis
Evidence
well supported
Published
11 October 2026

Key takeaway

What it shows: Fairly solid: results pooled from 26 trials in 2373 overweight or obese adults who were assigned at random to a device or app programme lasting at least 4 weeks. The trials used many different products, so no single brand can take the credit.

Study details

Design
Meta-analysis
Authors
Dehghan Ghahfarokhi A, Vosadi E, Barzegar H, Saatchian V
Journal
Biol Res Nurs
Published
2022
Added to Pulse
11 October 2026

Why it matters

Most adults carrying excess weight know they should move more; the hard part is sticking with it. Wearables and smartphone apps promise a cheap, always-on nudge, counting steps, logging workouts and connecting users to health professionals. The pandemic made remote options even more relevant as in-person programmes became harder to access. The open question was whether these digital tools genuinely shift activity, quality of life and cardiovascular health in overweight and obese adults, or whether the promise outruns the evidence.

What they did

The authors searched the relevant databases up to 18 November 2021 for trials in which overweight or obese adults were assigned at random to a wearable or smartphone-based intervention or to a control group. Only trials lasting 4 or more weeks were eligible. Outcomes included steps per day, moderate-to-vigorous physical activity, quality of life, body weight, body mass index, blood pressure and resting heart rate. Twenty-six studies covering 2373 participants met the criteria and were pooled.

What they found

People given wearables or apps took more steps per day and did more moderate-to-vigorous activity than controls, and they reported better quality of life. Body weight fell by an average of 1.61 kg more in the intervention groups, and body mass index dropped by 0.59 units. Cardiovascular measures were the exception: systolic and diastolic blood pressure and resting heart rate showed no significant differences between groups. So the tools moved behaviour and weight, but not the heart measures, within the trial periods studied.

Where it fits

This pooled analysis strengthens the case that digital self-tracking can change behaviour, something earlier individual trials had suggested with mixed results. The weight change is real but modest, roughly what you would expect from somewhat more daily movement rather than a structured diet. The lack of effect on blood pressure and resting heart rate leaves open whether longer or more intensive digital programmes could shift cardiovascular measures. It also remains unclear which ingredient does the work: the device, the app, or the direct line to health professionals the authors highlight.

What it means for you

If you are overweight and considering a tracker or activity app, this is evidence the approach can genuinely increase how much you move and nudge your weight down. The honest sizing matters: an average of 1.61 kg is meaningful but modest, and your blood pressure is unlikely to change on this evidence alone. The findings come from many different devices and apps pooled together, so no single product can claim this result. Think of the technology as a persistent prompt to move rather than a therapy in itself.

The source

The Effect of Wearable and Smartphone Applications on Physical Activity, Quality of Life, and Cardiovascular Health Outcomes in Overweight/Obese Adults: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Biol Res Nurs 2022

DOI: 10.1177/10998004221099556

Read the study →

Related tools & guides

More research, with the reality check: every study we hold → · this week’s → · or open the full Pulse feed →